SEC Form 4 · accession 0001140361-18-027795
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard A Meier
Director
Period of report
Jun 5, 2018
Accepted (ET)
Jun 7, 2018 · 8:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 5, 2018 | A | 4,300 | $0.00 | A | 56,610 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted stock units granted on June 5, 2018. Price not applicable.
- F2Amount of securities beneficially owned has been updated from the reporting person's prior report to include 1,000 shares inadvertently omitted from prior reports based on a reconciliation with the Company's records.